Showing results (1501-1510 of 6,159) with videos related to
Sort By:
Pageof 616
Nature Medicine|June 10, 2026
Dual-target gene therapy in Parkinson's disease: a multicenter phase 1 trialMengyue Niu, Jifeng Guo, Yuchao Yang, et al.Nature Medicine|June 1, 2026
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trialBernhard Gentner, Marica Eoli, Francesca Farina, et al.Nature Medicine|June 2, 2026
15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trialLukas Bethlehem, Lorenza Bartu, Gina Marke, et al.Nature Medicine|June 4, 2026
Human microglial transitions at the Aβ-tau inflection point associate with divergent pathways to dementia and resilienceAshley Lu, Wei-Ting Chen, Maria Dalby, et al.Nature Medicine|June 15, 2026
Adaptive deep brain stimulation for dynamic gait control in Parkinson's disease: a randomized feasibility trialKenneth H Louie, Jannine P Balakid, Jessica E Bath, et al.Nature Medicine|July 1, 2026
Clinical decision support in hematological malignancies using a case-grounded AI agentJulian Zoller, Michael Kalz, Xuewei Wu, et al.Nature Medicine|July 1, 2026
A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trialsQianqian Yang, Zeinab Bidel, Dexter Canoy, et al.Nature Medicine|July 3, 2026
Generalizable AI predicts immunotherapy outcomes across cancers and treatmentsWanxiang Shen, Intae Moon, Thinh H Nguyen, et al.Nature Medicine|July 7, 2026
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trialDeborah A Theodore, Bryan T Mayer, Charlotte-Paige Rolle, et al.Nature Medicine|July 9, 2026
Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trialG Paul, H Bjartmarz, A Kirkeby, et al.Pageof 616